Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today announced the appointment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback